We have "every confidence that community pharmacist adverse drug reaction reporting is a worthwhile enterprise," the chairman of the Committee on Safety of Medicines (Professor Alasdair Breckenridge) said last week.
|
Alasdair Breckenridge: "We are always trying to improve the yellow card system" |
Professor Breckenridge said that the CSM and MCA were still cautious about direct patient reporting of adverse reactions, although this might come at some later date. He emphasised that many adverse drug reactions were due to interactions, which could occur between prescribed and over-the-counter drugs. Patients could be diffident about disclosing their self-medication to doctors but might report to pharmacists, who would, therefore, be in a good position to pick up the interactions.
Also speaking at the launch meeting, Dr Keith Jones (chief executive, Medicines Control Agency) said that community pharmacist involvement in the "yellow card" scheme "will extend reporting and will also capture information we would otherwise not have on OTC medicines and alternative medicines".
The President of the Royal Pharmaceutical Society (Mrs Christine Glover) said that ADR reporting offered community pharmacists a unique opportunity to become more involved in patient care. "I encourage all our members to take up the challenge as reporters," she said.